详情页 - 首都医科大学附属北京同仁医院知识库

当前位置：首页 > 详情页

The Effect of Exogenous Creatine Phosphate on Myocardial Injury After Percutaneous Coronary Intervention

1| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Capital Med Univ, Dept Cardiol, Beijing Anzhen Hosp, Beijing 100029, Peoples R China [2]Capital Med Univ, Dept Cardiol, Beijing Tongren Hosp, Beijing 100029, Peoples R China

出处：

DOI：

ISSN：

关键词： creatine phosphate percutaneous coronary intervention myocardial injury

摘要：

Objective: To evaluate the effect of exogenous creatine phosphate (CP) on myocardial injury after percutaneous coronary intervention (PCI). Method: Four hundred patients were divided to receive conventional therapy (control group) or 3-day intravenous infusion of CP after PCI (CP group). Levels of creatine kinase MB (CK-MB) and troponin I (TnI) were measured before and on postprocedural day 3. Results: Postprocedural CK-MB and TnI in the CP group were significantly increased compared to the control group. In the CP group, 8.0% and 5.0% of patients had an increase in CK-MB 1 to 3 times and >3 times, respectively, which were significantly lower than that of the control group (19.0% and 9.0%, respectively); 12.0% and 10.0% of patients had an increase in TnI 1 to 3 times and >3 times, respectively, which were significantly lower than that of the control group (21.0% and 18.0%, respectively). Conclusion: Exogenous CP was helpful to reduce myocardial injury after PCI.

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2014]版：

大类 | 4 区医学

小类 | 4 区外周血管病

最新[2023]版：

大类 | 3 区医学

小类 | 3 区外周血管病

JCR分区：

出版当年[2013]版：

Q3 PERIPHERAL VASCULAR DISEASE

最新[2023]版：

Q2 PERIPHERAL VASCULAR DISEASE

影响因子： 2.6 最新[2023版] 2.6 最新五年平均 2.37 出版当年[2013版] 1.586 出版当年五年平均 1.647 出版前一年[2012版] 2.97 出版后一年[2014版]

第一作者：

第一作者机构： [1]Capital Med Univ, Dept Cardiol, Beijing Anzhen Hosp, Beijing 100029, Peoples R China [2]Capital Med Univ, Dept Cardiol, Beijing Tongren Hosp, Beijing 100029, Peoples R China

通讯作者：

通讯机构： [1]Capital Med Univ, Dept Cardiol, Beijing Anzhen Hosp, Beijing 100029, Peoples R China [*1]Capital Med Univ, Dept Cardiol, Beijing Anzhen Hosp, 12th Ward, Beijing 100029, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]THE SAFETY AND EFFICIENCY OF DALTEPARIN DURING PERCUTANEOUS CORONARY INTERVENTION [2]急性st段抬高型心肌梗死患者早期pci术后继发心肌缺血再灌注损伤危险因素分析 [3]Role of Rivaroxaban in the Antithrombotic Treatment of Patients with Coronary Heart Disease and Atrial Fibrillation after Percutaneous Coronary Intervention [4]Association of obstructive sleep apnea with cardiovascular outcomes after percutaneous coronary intervention: A systematic review and meta-analysis [5]Impact of obstructive sleep apnea on cardiovascular outcomes after percutaneous coronary intervention: a systematic review and meta-analysis [6]Predictive value of cardiopulmonary fitness parameters in the prognosis of patients with acute coronary syndrome after percutaneous coronary intervention [7]Serum YKL-40 predicts long-term outcome in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction [8]Predictive models for adverse clinical outcomes in Chinese patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting [9]XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China [10]A Risk Score for No Reflow in Patients With ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention